Rayto Hemaray-86 5-Part Hematology Analyzer Clinical Analytical Instruments Lab Supplies

Name: Rayto Hemaray-86 5-Part Hematology Analyzer Clinical Analytical Instruments Lab Supplies
Brand: Nanjing Long Medical Technology Co., Ltd.
SKU: 2152472105

Jiangsu, ChinaNanjing Long Medical Technology Co., Ltd.

US$2,100.00-6,500.00

1 set

Product profile

Customization

Available

Classification

Hematology Analyzer

Type

Hematology Analyzer

Model NO.

LHX-21

Certification

Product Name

5 Part Auto Hematology Analyzer

Measuring Principle

Laser Scatter Technology

Power Supply

AC220V±10% 50/60Hz; 110V±10% 60Hz; 6

Test Mode

Cbc+5diff, Cbc

Compute

External Optional

Lis Interface

Support Hl7 Protocol

Throughput

60tests/Hour

Incubation

Integral Titanium Incubation System

Transport Package

Standard Export Package

Specification

75KG

Trademark

LongMed

Origin

China

Production Capacity

10000000

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceSelf-branded

Nanjing Long Medical Technology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 10 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.77h

AI-Powered supplier vetting

SummaryNanjing Long Medical Technology Co., Ltd. is a China-based trading company established in 2016, with approximately 9–10 employees and a broad medical-equipment portfolio. It reports OEM service for well-known brands, ODM availability, multiple customization options, inventory capability, documented corrective-action and complaint-handling procedures, and quality assurance. Its stated lead time is within 15 working days in both peak and off-season periods. The supplier reports FDA China certification for all products and CE and FDA audit passage for most products, although the exact certificates and scope are not detailed. Financial-related records are present for 2023–2025, but the supplied fields do not provide assessable financial metrics. The supplier reports no new products in the past year, no available SDK, no overseas warehouses, branches, agents, or showrooms, and no participation in offline trade shows. Production capacity and verified customer cases are not sufficiently evidenced.

CertificationsThe company states that all products have been certified by FDA China, while most have passed CE and FDA certificate audits; CE is also listed as a sustainable development and product certification capability. The exact certificate documents, products covered, and validity periods are not provided, so the claimed coverage cannot be fully verified.

After-Sales capabilityThe company describes its products as having perfect after-service and reports clear procedures with followed records for customer complaints and corrective and preventive actions. Quality assurance is also stated, providing explicit evidence of structured post-sale and quality-response processes.

R&D capabilityThe supplier reports no new products during the past year and no available SDK, which are explicit limitations for recent product development and software-development support. It does provide ODM service, but this does not offset the stated lack of recent new products and SDK availability.

Customization capabilityThe supplier explicitly offers customization from samples, designs, full customization, minor customization, and flexible customization, and also reports ODM service. These statements directly support a broad customization offering.